Cargando…
Limitations of Sulforhodamine 101 for Brain Imaging
Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as speci...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328990/ https://www.ncbi.nlm.nih.gov/pubmed/28293173 http://dx.doi.org/10.3389/fncel.2017.00044 |
_version_ | 1782510969386172416 |
---|---|
author | Hülsmann, Swen Hagos, Liya Heuer, Heike Schnell, Christian |
author_facet | Hülsmann, Swen Hagos, Liya Heuer, Heike Schnell, Christian |
author_sort | Hülsmann, Swen |
collection | PubMed |
description | Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as specific for astrocytes as previously reported; and (ii) discoveries of severe excitatory side effects of SR101 are bearing the risk of unwanted alteration of the system of interest. In this article, we summarize the current knowledge about SR101-labeling protocols and discuss the problems that arise from varying of the staining protocols. Furthermore, we provide a testable hypothesis for the observed hyper-excitability that can be observed when using SR101. |
format | Online Article Text |
id | pubmed-5328990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53289902017-03-14 Limitations of Sulforhodamine 101 for Brain Imaging Hülsmann, Swen Hagos, Liya Heuer, Heike Schnell, Christian Front Cell Neurosci Neuroscience Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as specific for astrocytes as previously reported; and (ii) discoveries of severe excitatory side effects of SR101 are bearing the risk of unwanted alteration of the system of interest. In this article, we summarize the current knowledge about SR101-labeling protocols and discuss the problems that arise from varying of the staining protocols. Furthermore, we provide a testable hypothesis for the observed hyper-excitability that can be observed when using SR101. Frontiers Media S.A. 2017-02-28 /pmc/articles/PMC5328990/ /pubmed/28293173 http://dx.doi.org/10.3389/fncel.2017.00044 Text en Copyright © 2017 Hülsmann, Hagos, Heuer and Schnell. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Hülsmann, Swen Hagos, Liya Heuer, Heike Schnell, Christian Limitations of Sulforhodamine 101 for Brain Imaging |
title | Limitations of Sulforhodamine 101 for Brain Imaging |
title_full | Limitations of Sulforhodamine 101 for Brain Imaging |
title_fullStr | Limitations of Sulforhodamine 101 for Brain Imaging |
title_full_unstemmed | Limitations of Sulforhodamine 101 for Brain Imaging |
title_short | Limitations of Sulforhodamine 101 for Brain Imaging |
title_sort | limitations of sulforhodamine 101 for brain imaging |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328990/ https://www.ncbi.nlm.nih.gov/pubmed/28293173 http://dx.doi.org/10.3389/fncel.2017.00044 |
work_keys_str_mv | AT hulsmannswen limitationsofsulforhodamine101forbrainimaging AT hagosliya limitationsofsulforhodamine101forbrainimaging AT heuerheike limitationsofsulforhodamine101forbrainimaging AT schnellchristian limitationsofsulforhodamine101forbrainimaging |